Intestinal Diseases Model - Global Top Players Market Share and Ranking 2025- YH Research

Home > Reports >Medical Devices & Consumables > Intestinal Diseases Model - Global Top Players Market Share and Ranking 2025

Intestinal Diseases Model - Global Top Players Market Share and Ranking 2025

Publication Date: 2025-11-23
Report Id: 2809347
Industry: Medical Devices & Consumables
Report Page: 118
Chart: 113

PDF Download

Publication Date: 2025-11-23
Report Id: 2809347
Industry: Medical Devices & Consumables
Report Page: 118
Chart: 113

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Intestinal Diseases Model Definition
1.2 Global Intestinal Diseases Model Market Size and Forecast
1.2.1 By Consumption Value, Global Intestinal Diseases Model Market Size, 2020-2031
1.2.2 By Sales Quantity, Global Intestinal Diseases Model Market Size, 2020-2031
1.2.3 Global Intestinal Diseases Model Average Selling Price (ASP), 2020-2031
1.3 China Intestinal Diseases Model Market Size and Forecast
1.3.1 By Consumption Value, China Intestinal Diseases Model Market Size, 2020-2031
1.3.2 By Sales Quantity, China Intestinal Diseases Model Market Size, 2020-2031
1.3.3 China Intestinal Diseases Model Average Selling Price (ASP), 2020-2031
1.4 Share of China Intestinal Diseases Model Market with Respect to the Global Market
1.4.1 By Consumption Value, China Intestinal Diseases Model Market Share in Global, 2020-2031
1.4.2 By Sales Quantity, China Intestinal Diseases Model Market Share in Global, 2020-2031
1.4.3 Intestinal Diseases Model Market Size: China VS Global, 2020-2031
1.5 Intestinal Diseases Model Market Dynamics
1.5.1 Intestinal Diseases Model Market Drivers
1.5.2 Intestinal Diseases Model Market Restraints
1.5.3 Intestinal Diseases Model Industry Trends
1.5.4 Intestinal Diseases Model Industry Policy

2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Intestinal Diseases Model, Global Market Share by Company, 2020-2025
2.2 By Sales Quantity of Intestinal Diseases Model, Global Market Share by Company, 2020-2025
2.3 Intestinal Diseases Model Average Selling Price (ASP) by Company, 2020-2025
2.4 Global Intestinal Diseases Model Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Intestinal Diseases Model Concentration Ratio
2.6 Global Intestinal Diseases Model Mergers & Acquisitions, Expansion Plans
2.7 Global Intestinal Diseases Model Manufacturers Product Type
2.8 Head Office and Intestinal Diseases Model Production Site of Key Manufacturer
2.9 Intestinal Diseases Model Capacity of Major Manufacturers and Future Plan

3 China Leading Manufacturers and Market Share
3.1 By Revenue of Intestinal Diseases Model, China Market Share by Company, 2020-2025
3.2 By Sales Quantity of Intestinal Diseases Model, China Market Share by Company, 2020-2025
3.3 China Intestinal Diseases Model Intestinal Diseases Model Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions
4.1 Global Intestinal Diseases Model Capacity, Output and Capacity Utilization, 2020-2031
4.2 Global Intestinal Diseases Model Capacity by Region
4.3 Global Intestinal Diseases Model Production & Forecast by Region, 2020 VS 2024 VS 2031
4.4 Global Intestinal Diseases Model Production by Region, 2020-2031
4.5 Global Intestinal Diseases Model Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 Intestinal Diseases Model Industry Chain
5.2 Intestinal Diseases Model Upstream Analysis
5.2.1 Intestinal Diseases Model Core Raw Materials
5.2.2 Main Manufacturers of Intestinal Diseases Model Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Intestinal Diseases Model Production Mode
5.6 Intestinal Diseases Model Procurement Model
5.7 Intestinal Diseases Model Industry Sales Model and Sales Channels
5.7.1 Intestinal Diseases Model Sales Model
5.7.2 Intestinal Diseases Model Typical Distributors

6 Sights by Type
6.1 Intestinal Diseases Model Classification by Type
6.1.1 Whole Colon Pathological Model
6.1.2 Local Cross-Sectional Model
6.1.3 Others
6.2 by Type, Global Intestinal Diseases Model Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Intestinal Diseases Model Consumption Value, 2020-2031
6.4 by Type, Global Intestinal Diseases Model Sales Quantity, 2020-2031
6.5 by Type, Global Intestinal Diseases Model Average Selling Price (ASP), 2020-2031

7 Sights by Disease Type
7.1 Intestinal Diseases Model Classification by Disease Type
7.1.1 PVC Casting Models
7.1.2 Composite Material Models
7.1.3 Others
7.2 by Disease Type, Global Intestinal Diseases Model Consumption Value & CAGR, 2020 VS 2024 VS 2031
7.3 by Disease Type, Global Intestinal Diseases Model Consumption Value, 2020-2031
7.4 by Disease Type, Global Intestinal Diseases Model Sales Quantity, 2020-2031
7.5 by Disease Type, Global Intestinal Diseases Model Average Selling Price (ASP), 2020-2031

8 Sights by Material and Craftsmanship
8.1 Intestinal Diseases Model Classification by Material and Craftsmanship
8.1.1 Basic Anatomy
8.1.2 Public Science Popularization Exhibition
8.1.3 Others
8.2 by Material and Craftsmanship, Global Intestinal Diseases Model Consumption Value & CAGR, 2020 VS 2024 VS 2031
8.3 by Material and Craftsmanship, Global Intestinal Diseases Model Consumption Value, 2020-2031
8.4 by Material and Craftsmanship, Global Intestinal Diseases Model Sales Quantity, 2020-2031
8.5 by Material and Craftsmanship, Global Intestinal Diseases Model Average Selling Price (ASP), 2020-2031

9 Sights by Application
9.1 Intestinal Diseases Model Segment by Application
9.1.1 Hospital
9.1.2 Specialist Clinic
9.1.3 Others
9.2 by Application, Global Intestinal Diseases Model Consumption Value & CAGR, 2020 VS 2024 VS 2031
9.3 by Application, Global Intestinal Diseases Model Consumption Value, 2020-2031
9.4 by Application, Global Intestinal Diseases Model Sales Quantity, 2020-2031
9.5 by Application, Global Intestinal Diseases Model Price, 2020-2031

10 Sales Sights by Region
10.1 By Region, Global Intestinal Diseases Model Consumption Value, 2020 VS 2024 VS 2031
10.2 By Region, Global Intestinal Diseases Model Consumption Value, 2020-2031
10.3 By Region, Global Intestinal Diseases Model Sales Quantity, 2020-2031
10.4 North America
10.4.1 North America Intestinal Diseases Model Market Size & Forecasts, 2020-2031
10.4.2 By Country, North America Intestinal Diseases Model Market Size Market Share
10.5 Europe
10.5.1 Europe Intestinal Diseases Model Market Size & Forecasts, 2020-2031
10.5.2 By Country, Europe Intestinal Diseases Model Market Size Market Share
10.6 Asia Pacific
10.6.1 Asia Pacific Intestinal Diseases Model Market Size & Forecasts, 2020-2031
10.6.2 By Country/Region, Asia Pacific Intestinal Diseases Model Market Size Market Share
10.7 South America
10.7.1 South America Intestinal Diseases Model Market Size & Forecasts, 2020-2031
10.7.2 By Country, South America Intestinal Diseases Model Market Size Market Share
10.8 Middle East & Africa

11 Sales Sights by Country Level
11.1 By Country, Global Intestinal Diseases Model Market Size & CAGR, 2020 VS 2024 VS 2031
11.2 By Country, Global Intestinal Diseases Model Consumption Value, 2020-2031
11.3 By Country, Global Intestinal Diseases Model Sales Quantity, 2020-2031
11.4 United States
11.4.1 United States Intestinal Diseases Model Market Size, 2020-2031
11.4.2 by Type, United States Intestinal Diseases Model Sales Quantity Market Share, 2024 VS 2031
11.4.3 by Application, United States Intestinal Diseases Model Sales Quantity Market Share, 2024 VS 2031
11.5 Europe
11.5.1 Europe Intestinal Diseases Model Market Size, 2020-2031
11.5.2 by Type, Europe Intestinal Diseases Model Sales Quantity Market Share, 2024 VS 2031
11.5.3 by Application, Europe Intestinal Diseases Model Sales Quantity Market Share, 2024 VS 2031
11.6 China
11.6.1 China Intestinal Diseases Model Market Size, 2020-2031
11.6.2 by Type, China Intestinal Diseases Model Sales Quantity Market Share, 2024 VS 2031
11.6.3 by Application, China Intestinal Diseases Model Sales Quantity Market Share, 2024 VS 2031
11.7 Japan
11.7.1 Japan Intestinal Diseases Model Market Size, 2020-2031
11.7.2 by Type, Japan Intestinal Diseases Model Sales Quantity Market Share, 2024 VS 2031
11.7.3 by Application, Japan Intestinal Diseases Model Sales Quantity Market Share, 2024 VS 2031
11.8 South Korea
11.8.1 South Korea Intestinal Diseases Model Market Size, 2020-2031
11.8.2 by Type, South Korea Intestinal Diseases Model Sales Quantity Market Share, 2024 VS 2031
11.8.3 by Application, South Korea Intestinal Diseases Model Sales Quantity Market Share, 2024 VS 2031
11.9 Southeast Asia
11.9.1 Southeast Asia Intestinal Diseases Model Market Size, 2020-2031
11.9.2 by Type, Southeast Asia Intestinal Diseases Model Sales Quantity Market Share, 2024 VS 2031
11.9.3 by Application, Southeast Asia Intestinal Diseases Model Sales Quantity Market Share, 2024 VS 2031
11.10 India
11.10.1 India Intestinal Diseases Model Market Size, 2020-2031
11.10.2 by Type, India Intestinal Diseases Model Sales Quantity Market Share, 2024 VS 2031
11.10.3 by Application, India Intestinal Diseases Model Sales Quantity Market Share, 2024 VS 2031
11.11 Middle East & Africa
11.11.1 Middle East & Africa Intestinal Diseases Model Market Size, 2020-2031
11.11.2 by Type, Middle East & Africa Intestinal Diseases Model Sales Quantity Market Share, 2024 VS 2031
11.11.3 by Application, Middle East & Africa Intestinal Diseases Model Sales Quantity Market Share, 2024 VS 2031

12 Manufacturers Profile
12.1 3B Scientific
12.1.1 3B Scientific Company Information, Head Office, Market Area, and Industry Position
12.1.2 3B Scientific Intestinal Diseases Model Models, Specifications, and Application
12.1.3 3B Scientific Intestinal Diseases Model Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.1.4 3B Scientific Company Profile and Main Business
12.1.5 3B Scientific Recent Developments
12.2 Nasco Healthcare
12.2.1 Nasco Healthcare Company Information, Head Office, Market Area, and Industry Position
12.2.2 Nasco Healthcare Intestinal Diseases Model Models, Specifications, and Application
12.2.3 Nasco Healthcare Intestinal Diseases Model Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.2.4 Nasco Healthcare Company Profile and Main Business
12.2.5 Nasco Healthcare Recent Developments
12.3 GPI Anatomicals
12.3.1 GPI Anatomicals Company Information, Head Office, Market Area, and Industry Position
12.3.2 GPI Anatomicals Intestinal Diseases Model Models, Specifications, and Application
12.3.3 GPI Anatomicals Intestinal Diseases Model Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.3.4 GPI Anatomicals Company Profile and Main Business
12.3.5 GPI Anatomicals Recent Developments
12.4 Erler-Zimmer
12.4.1 Erler-Zimmer Company Information, Head Office, Market Area, and Industry Position
12.4.2 Erler-Zimmer Intestinal Diseases Model Models, Specifications, and Application
12.4.3 Erler-Zimmer Intestinal Diseases Model Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.4.4 Erler-Zimmer Company Profile and Main Business
12.4.5 Erler-Zimmer Recent Developments
12.5 SOMSO
12.5.1 SOMSO Company Information, Head Office, Market Area, and Industry Position
12.5.2 SOMSO Intestinal Diseases Model Models, Specifications, and Application
12.5.3 SOMSO Intestinal Diseases Model Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.5.4 SOMSO Company Profile and Main Business
12.5.5 SOMSO Recent Developments
12.6 Axis Scientific
12.6.1 Axis Scientific Company Information, Head Office, Market Area, and Industry Position
12.6.2 Axis Scientific Intestinal Diseases Model Models, Specifications, and Application
12.6.3 Axis Scientific Intestinal Diseases Model Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.6.4 Axis Scientific Company Profile and Main Business
12.6.5 Axis Scientific Recent Developments
12.7 Denoyer-Geppert
12.7.1 Denoyer-Geppert Company Information, Head Office, Market Area, and Industry Position
12.7.2 Denoyer-Geppert Intestinal Diseases Model Models, Specifications, and Application
12.7.3 Denoyer-Geppert Intestinal Diseases Model Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.7.4 Denoyer-Geppert Company Profile and Main Business
12.7.5 Denoyer-Geppert Recent Developments
12.8 Health Edco
12.8.1 Health Edco Company Information, Head Office, Market Area, and Industry Position
12.8.2 Health Edco Intestinal Diseases Model Models, Specifications, and Application
12.8.3 Health Edco Intestinal Diseases Model Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.8.4 Health Edco Company Profile and Main Business
12.8.5 Health Edco Recent Developments
12.9 MeiWo Science
12.9.1 MeiWo Science Company Information, Head Office, Market Area, and Industry Position
12.9.2 MeiWo Science Intestinal Diseases Model Models, Specifications, and Application
12.9.3 MeiWo Science Intestinal Diseases Model Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.9.4 MeiWo Science Company Profile and Main Business
12.9.5 MeiWo Science Recent Developments
12.10 3-Dmed
12.10.1 3-Dmed Company Information, Head Office, Market Area, and Industry Position
12.10.2 3-Dmed Intestinal Diseases Model Models, Specifications, and Application
12.10.3 3-Dmed Intestinal Diseases Model Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.10.4 3-Dmed Company Profile and Main Business
12.10.5 3-Dmed Recent Developments
12.11 Simulab Corporation
12.11.1 Simulab Corporation Company Information, Head Office, Market Area, and Industry Position
12.11.2 Simulab Corporation Intestinal Diseases Model Models, Specifications, and Application
12.11.3 Simulab Corporation Intestinal Diseases Model Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.11.4 Simulab Corporation Company Profile and Main Business
12.11.5 Simulab Corporation Recent Developments

13 Conclusion

14 Appendix
14.1 Research Methodology
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Market Estimation Model
14.4 Disclaimer

According to YH Research, the global market for Intestinal Diseases Model should grow from US$ 32.03 million in 2024 to US$ 50.67 million by 2031, with a CAGR of 6.8% for the period of 2025-2031.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Intestinal Diseases Model

According to YH Research, the global market for Intestinal Diseases Model should grow from US$ 32.03 million in 2024 to US$ 50.67 million by 2031, with a CAGR of 6.8% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

In 2024, global Intestinal Diseases Model production reached approximately 334,666 units, with an average global market price of around US$ 90 per unit.Intestinal disease models typically refer to anatomical and pathological teaching models that primarily feature segments of the colon or rectum, showcasing common lesions such as polyps, cancer, diverticulitis, ulcerative colitis, and Crohn's disease. These models are often made of PVC, resin, or composite materials, presenting normal intestinal structures and various typical lesions in a three-dimensional format, facilitating medical education, clinical instruction, and patient communication. Common products are often cross-sectional or whole-colon "section + lesion collection" models, accompanied by instruction cards that clearly demonstrate the mucosal layer, muscular layer, and lesion morphology.

Gross Profit Margin Analysis
From a cost structure perspective, intestinal disease models belong to the mid-to-high-priced category of digestive system anatomical models. Their costs mainly consist of mold and development amortization, raw materials (PVC/resin/3D printing materials), painting and assembly labor, quality control, and distribution channels and cross-border logistics. Standard PVC pathological colon models have relatively low unit material and processing costs after mold finalization. Combined with their moderate product size and controllable transportation losses, the gross profit margin after large-scale production is relatively considerable. Based on company interviews and projections of similar anatomical model categories, international brands, relying on brand premium, channel control, and AR/digital content added value, generally maintain a gross profit margin in the 55%–65% range. Meanwhile, mid-to-low-end manufacturers, mainly relying on cross-border e-commerce and OEM/ODM, often adopt a "low-profit, high-volume" strategy, competing in the $10–40 price range, with gross profit margins typically falling between 35% and 50%. Overall, the gross profit margin of intestinal disease models is similar to or even slightly higher than that of other anatomical and pathological models, mainly due to their rigid demand in patient education and public health, as well as their strong bargaining power.

Industry Drivers
The core growth in demand for intestinal disease models comes from three main directions. First, the global medical education and continuing education system continues to place increasing emphasis on "visualization + simulation teaching." Medical schools, nursing schools, and simulation centers rely more on three-dimensional models and case-based pathological specimens in anatomy and pathology teaching. The digestive system, especially high-incidence diseases such as colorectal cancer and IBD, has become a teaching focus, thus driving colonic pathology models to become a standard component of teaching equipment. Second, increased public awareness of colorectal cancer screening and IBD management has prompted hospitals, oncology centers, and gastroenterology departments to increase investment in patient education. Vivid intestinal disease models can intuitively demonstrate the chain of polyp malignant transformation and the long-term damage of inflammatory bowel disease, serving as an efficient tool for doctors to explain diseases and treatment plans to patients. Simultaneously, pharmaceutical companies and public health institutions are also purchasing large quantities of such models for demonstration purposes in cancer screening promotion and IBD patient education projects. Thirdly, technological advancements and product innovation—3D-printed pathological specimens enhance the realism of models, functional "disease models" such as organoids and intestinal chips provide new platforms for scientific research and drug development, while AR/VR interactive content enables the "digital upgrade" of traditional physical models, significantly enhancing the teaching and self-learning experience. In summary, the upgrading of medical education, the strengthening of patient education, the increasing burden of cancer and chronic bowel diseases, and the integration of 3D printing and digital simulation technologies are key drivers supporting the continued medium-to-high-speed growth of intestinal disease models in the coming years.

This report studies and analyses global Intestinal Diseases Model status and future trends, helps the client to determine the Intestinal Diseases Model market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Intestinal Diseases Model, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2024 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Intestinal Diseases Model market size, history data 2020-2025, and forecast data 2026-2031, (US$ million) & (K Units)
(2) Global Intestinal Diseases Model sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (K Units)
(3) China Intestinal Diseases Model sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (K Units)
(4) Global Intestinal Diseases Model key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Intestinal Diseases Model key producing regions, capacity, production, and year over year growth
(6) Intestinal Diseases Model industry chains, upstream, midstream and downstream
Market segment by players, this report covers
3B Scientific
Nasco Healthcare
GPI Anatomicals
Erler-Zimmer
SOMSO
Axis Scientific
Denoyer-Geppert
Health Edco
MeiWo Science
3-Dmed
Simulab Corporation

Market segment by Type, covers
Whole Colon Pathological Model
Local Cross-Sectional Model
Others

Market segment by Disease Type, covers
PVC Casting Models
Composite Material Models
Others

Market segment by Material and Craftsmanship, covers
Basic Anatomy
Public Science Popularization Exhibition
Others

Market segment by Application, can be divided into
Hospital
Specialist Clinic
Others

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Intestinal Diseases Model product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Intestinal Diseases Model market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 3: China Intestinal Diseases Model market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 4: Global key producing regions of Intestinal Diseases Model, percent & CAGR, 2020-2031
Chapter 5: Intestinal Diseases Model industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.